|
Nov 6
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
|
Nov 6
|
Biotech/Drug Stocks Q3 Earnings Due Nov 7: GILD, PRGO, VTRS & More
|
|
Nov 5
|
Is Viatris (VTRS) a Smart Long-Term Pick?
|
|
Sep 12
|
Viatris Named to TIME's World’s Best Companies 2023 List
|
|
Sep 9
|
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
|
|
Sep 6
|
Unveiling Viatris (VTRS)'s Value: Is It Really Priced Right? A Comprehensive Guide
|
|
Sep 6
|
Unraveling the Future of Viatris Inc (VTRS): A Deep Dive into Key Metrics
|
|
Sep 6
|
Why Is Viatris (VTRS) Down 4.8% Since Last Earnings Report?
|
|
Aug 11
|
2 Beaten-Down Dividend Stocks to Buy
|
|
Aug 11
|
If You'd Invested $25,000 in Viatris in 2020, This Is How Much You Would Have Today
|
|
Aug 10
|
Viatris Has Been Bearish for One Reason — But Is Still an Intriguing Value Play
|
|
Aug 10
|
Viatris Inc. (NASDAQ:VTRS) Q2 2023 Earnings Call Transcript
|
|
Aug 9
|
Is Viatris Stock Good for Dividend Income?
|
|
Aug 8
|
Theravance's (TBPH) Q2 Earnings Beat Estimates, Revenues Miss
|
|
Aug 8
|
Company News for Aug 8, 2023
|
|
Aug 8
|
Q2 2023 Viatris Inc Earnings Call
|
|
Aug 8
|
Viatris (VTRS) Reports Q2 Earnings: What Key Metrics Have to Say
|
|
Aug 7
|
S&P 500 Gains and Losses Today: Stocks Take Off After Earnings Reports
|
|
Aug 7
|
Viatris Shares Gain on Sales, Divestitures, and FDA Review of Its MS Drug
|
|
Aug 7
|
Markets Higher at Midday on New Earnings Reports, Upcoming Data
|